Statement was made by Dr Kauffmann (Boston Children's Hospital) bottom of pg 1 in italics.
I totally agree, the whole Autism spectrum is in play here, but will need the resources of Big Pharma to start trials in all the various potential applications. I am hoping Neuren does a licencing deal with royalties because the potential is so huge. But if I was Big Pharma I would be looking to buy them outright (cheap) and maximise the potential myself.
Importance of the trial results & challenges, page-6
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$14.57 |
Change
-0.040(0.27%) |
Mkt cap ! $1.813B | |||
| Open | High | Low | Value | Volume |
| $14.94 | $15.19 | $14.51 | $8.165M | 551.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2735 | $14.55 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.65 | 1396 | 1 |
View Market Depth
| Last trade - 16.10pm 11/07/2025 (20 minute delay) ? |
| NEU (ASX) Chart |